Mode
Text Size
Log in / Sign up
N/A N=41 Randomized Supportive Care

Decision Support Workshop for Breast Reconstruction

Breast Cancer

Enrolled (actual)
41
Serious AEs
Results posted
Jun 2015
Primary outcome: Primary: Decision Self-efficacy Scale — 5.7; 5.1 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Decision Support Workshop (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
University Health Network, Toronto
Primary completion
Jul 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Decision Self-efficacy Scale
5.7; 5.1
SECONDARY
Decision Conflict Scale
SECONDARY
Decision Preference and Decision Choice
SECONDARY
Patient Involvement in Care Scale (PICS)
SECONDARY
Satisfaction With Information (Sub-scale of BREAST-Q)
SECONDARY
Qualitative Interview Assessment
SECONDARY
Uptake Rate of Breast Reconstruction-Service Outcome
SECONDARY
Length of Consultation-service Outcome
SECONDARY
Number of Consultations-service Outcomes
SECONDARY
Breast Reconstruction Knowledge Test
SECONDARY
Medical Outcomes Study Social Support Survey

Summary

The purpose of this study is to determine the effectiveness of a pre-consultation decision support workshop for breast reconstruction after breast cancer, in facilitating the decision-making process, compared to routine pre-surgical education.

Eligibility Criteria

Inclusion Criteria

  • Patient age: 18 - 79 years at the time of consultation
  • In situ or invasive biopsy confirmed breast adenocarcinoma
  • Considered for immediate or delayed breast reconstruction
  • First consultation for breast reconstruction

Exclusion Criteria

  • Chest wall or atypical breast malignancy (ex: angiosarcoma) or inflammatory adenocarcinoma of the breast
  • Completion any phase of reconstruction, or for revision reconstruction
  • Patient cannot read or write in English.
  • Cognitive impairment or uncontrolled psychiatric diagnosis
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01857882). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search